Last reviewed · How we verify
NCT03730805: KhatAssist
The Adaptation and Evaluation of the WHO's ASSIST-linked Brief Intervention to Khat-Using Ethiopian University Students
NA trial testing ASSIST-linked Brief Intervention in Khat Abuse in 307 participants. Completed in 31 January 2019.
15 January 2019
Quick facts
| Lead sponsor | University of Konstanz |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 307 |
| Start date | 15 November 2018 |
| Primary completion | 15 January 2019 |
| Estimated completion | 31 January 2019 |
| Sites | 1 location across Ethiopia |
Drugs / interventions tested
- ASSIST-linked Brief Intervention
- Induction of Deliberative Mindset
- Induction of Implemental Mindset
Conditions studied
- Khat Abuse — all drugs for Khat Abuse →
Sponsor
University of Konstanz
Who can join
Adults 18 to 45, any sex, with Khat Abuse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The leaves of the khat tree (catha edulis) are traditionally chewed in the countries around the Horn of Africa. They contain the amphetamine-like alkaloid cathinone and their use can produce a Substance Use Disorder. The researchers intent to validate an Amharic and an Oromo version of the WHO's ASSIST-linked Brief Intervention among khat-using Ethiopian university students. In an RCT, khat using students of Jimma University with initial motivation to stop or cut down khat use will be randomised to either an intervention or a control group. In the intervention group, the WHO's ASSIST-linked BI will be delivered in a single session by trained local counsellors. In the control group, participants will receive a neuropsychological assessment (Raven's Standard Progressive Matrices, SPM; Raven, 1972). Khat use, the neuropsychological variables and psychiatric symptoms will be assessed before the intervention and two weeks after it. Additionally, the researchers will measure the participants resistance during the session. The control group will receive the intervention after the post test. In order to study state variables that influence brief intervention effectivity, e.g. by increasing or reducing resistance, the researchers randomise subjects in each study arm to several short pre-interventions that are based on Gollwitzer's empirically well established Mindset Theory of Action Phases (for summary: Gollwitzer \& Keller, 2016). This means, before delivering the ASSIST-linked BI (intervention group) or before the SPM assessment (controlgroup) a specific psychological state will be induced by a brief writing task that theoretically should affect the openness to the intervention: (1) implemental mindset, (2) deliberative mindset, (3) no mindset induction. The researchers expect that khat use will be reduced more in the intervention condition compared to the control condition and that induced states influence the effectiveness of the intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Khat Use Patterns, Associated Features, and Psychological Problems in a Khat-Treatment-Seeking Student Sample of Jimma University, Southwestern Ethiopia.
Hassen MT, Soboka M, Widmann M, Keller L, et al · · 2021 · cited 5× · PMID 34490174 · DOI 10.3389/fpubh.2021.645980
Verify or expand the search:
- PubMed search for NCT03730805
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ASSIST-linked Brief Intervention
Trials testing the same drug.
- NCT05167097 — Mindsets and the Effectiveness of a Brief Intervention - Replication · NA · completed
Other University of Konstanz trials
Trials by the same sponsor.
- NCT05167097 — Mindsets and the Effectiveness of a Brief Intervention - Replication · NA · completed
- NCT04985786 — Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and Schizophrenia · NA · unknown
- NCT04832035 — Integration of Refugees Into Public Mental Health Care · NA · unknown
- NCT05136105 — Preventing Trauma Symptoms in the Aftermath of Sexual Abuse in Children and Adolescents in Burundi · NA · completed
- NCT04061954 — Umuryango Ukomera Uri Hamwe - Families Are Strong Together · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03730805 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Konstanz
- Last refreshed: 24 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03730805.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing